The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity
Open accessAbstract
Certain HLA-B antigens have been associated with lack of progression to AIDS. HLA-B alleles can be divided into two mutually exclusive groups based on the expression of the molecular epitopes HLA-Bw4 and HLA-Bw6. Notably, in addition to its role in presenting viral peptides for immune recognition, the HLA-Bw4, but not HLA-Bw6, motif functions as a ligand for a natural killer cell inhibitory receptor (KIR). Here, we show that profound suppression of HIV-1 viremia is significantly associated with homozygosity for HLA-B alleles that share the HLA-Bw4 epitope. Furthermore, homozygosity for HLA-Bw4 alleles was also significantly associated with the ability to remain AIDS free and to maintain a normal CD4 T cell count in a second cohort of HIV-1-infected individuals with well defined dates of seroconversion. This association was independent of the presence of a mutation in CC chemokine receptor 5 (CCR5) associated with resistance to HIV-1 infection, and it was independent of the presence of HLA alleles that could potentially confound the results. We conclude that homozygosity for HLA-Bw4-bearing B alleles is associated with a significant advantage and that the HLA-Bw4 motif is important in AIDS pathogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Statistical Analysis of Failure Time Data.
Aitkin, M., Kalbfleisch, J. D., & Prentice, R. L. (1981) · Biometrics · doi:10.2307/2530581 · Cited by 9,877
Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in Plasma
Mellors, J. W., Rinaldo, C. R., Gupta, P., White, R. M., Todd, J. A., & Kingsley, L. A. (1996) · Science · doi:10.1126/science.272.5265.1167 · Cited by 2,660
Dean, M., Carrington, M., Winkler, C., Huttley, G. A., Smith, M. W., Allikmets, R., Goedert, J. J., Buchbinder, S. P., Vittinghoff, E., Gomperts, E., et al. (1996) · Science · doi:10.1126/science.273.5283.1856 · Cited by 2,484
Self-citationControl of Viremia in Simian Immunodeficiency Virus Infection by CD8 + Lymphocytes
Schmitz, J. E., Kuroda, M. J., Santra, S., Sasseville, V. G., Simon, M. A., Lifton, M. A., Racz, P., Tenner-Racz, K., Dalesandro, M., Scallon, B. J., et al. (1999) · Science · doi:10.1126/science.283.5403.857 · Cited by 2,187
Vigorous HIV-1-Specific CD4 + T Cell Responses Associated with Control of Viremia
Rosenberg, E. S., Billingsley, J. M., Caliendo, A. M., Boswell, S. L., Sax, P. E., Kalams, S. A., & Walker, B. D. (1997) · Science · doi:10.1126/science.278.5342.1447 · Cited by 1,835
Self-citationThe Statistical Analysis of Failure Time Data
Young, W. R. (1981) · Journal of Quality Technology · doi:10.1080/00224065.1981.11978770 · Cited by 1,666
Jin, X., Bauer, D. E., Tuttleton, S. E., Lewin, S., Gettie, A., Blanchard, J., Irwin, C. E., Safrit, J. T., Mittler, J., Weinberger, L., et al. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.6.991 · Cited by 1,407
Quantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNA
Ogg, G. S., Jin, X., Bonhoeffer, S., Dunbar, P. R., Nowak, M. A., Monard, S., Segal, J. P., Cao, Y., Rowland-Jones, S. L., Cerundolo, V., et al. (1998) · Science · doi:10.1126/science.279.5359.2103 · Cited by 1,383
HLA and HIV-1: Heterozygote Advantage and B*35-Cw*04 Disadvantage
Carrington, M., Nelson, G. W., Martin, M. P., Kissner, T., Vlahov, D., Goedert, J. J., Kaslow, R., Buchbinder, S., Hoots, K., & O'Brien, S. J. (1999) · Science · doi:10.1126/science.283.5408.1748 · Cited by 1,224
Self-citationCao, Y., Qin, L., Zhang, L., Safrit, J., & Ho, D. D. (1995) · New England Journal of Medicine · doi:10.1056/nejm199501263320401 · Cited by 1,037
HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes
Collins, K. L., Chen, B. K., Kalams, S. A., Walker, B. D., & Baltimore, D. (1998) · Nature · doi:10.1038/34929 · Cited by 1,021
Self-citationMigueles, S. A., Sabbaghian, M. S., Shupert, W. L., Bettinotti, M. P., Marincola, F. M., Martino, L., Hallahan, C. W., Selig, S. M., Schwartz, D., Sullivan, J., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.050567397 · Cited by 995
Kaslow, R. A., Carrington, M., Apple, R., Park, L., Muñoz, A., Saah, A. J., Goedert, J. J., Winkler, C., O'Brien, S. J., Rinaldo, C., et al. (1996) · Nature Medicine · doi:10.1038/nm0496-405 · Cited by 970
Contrasting Genetic Influence of CCR2 and CCR5 Variants on HIV-1 Infection and Disease Progression
Smith, M. W., Dean, M., Carrington, M., Winkler, C., Huttley, G. A., Lomb, D. A., Goedert, J. J., O'Brien, T. R., Jacobson, L. P., Kaslow, R., et al. (1997) · Science · doi:10.1126/science.277.5328.959 · Cited by 876
Self-citationCohen, G. B., Gandhi, R. T., Davis, D. M., Mandelboim, O., Chen, B. K., Strominger, J. L., & Baltimore, D. (1999) · Immunity · doi:10.1016/s1074-7613(00)80065-5 · Cited by 861
Direct Observation of Vortex Dynamics in Superconducting Films with Regular Arrays of Defects
Harada, K., Kamimura, O., Kasai, H., Matsuda, T., Tonomura, A., & Moshchalkov, V. V. (1996) · Science · doi:10.1126/science.274.5290.1167 · Cited by 778
Studies in Subjects with Long-Term Nonprogressive Human Immunodeficiency Virus Infection
Pantaleo, G., Menzo, S., Vaccarezza, M., Graziosi, C., Cohen, O. J., Demarest, J. F., Montefiori, D., Orenstein, J. M., Fox, C., Schrager, L. K., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199501263320402 · Cited by 730
Self-citationGenetic Restriction of AIDS Pathogenesis by an SDF-1 Chemokine Gene Variant
Winkler, C., Modi, W., Smith, M. W., Nelson, G. W., Wu, X., Carrington, M., Dean, M., Honjo, T., Tashiro, K., Yabe, D., et al. (1998) · Science · doi:10.1126/science.279.5349.389 · Cited by 710
Self-citationKlein, M. R., van Baalen, C. A., Holwerda, A. M., Kerkhof Garde, S. R., Bende, R. J., Keet, I. P., Eeftinck-Schattenkerk, J. K., Osterhaus, A. D., Schuitemaker, H., & Miedema, F. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.4.1365 · Cited by 638
Kalams, S. A., Buchbinder, S. P., Rosenberg, E. S., Billingsley, J. M., Colbert, D. S., Jones, N. G., Shea, A. K., Trocha, A. K., & Walker, B. D. (1999) · Journal of Virology · doi:10.1128/jvi.73.8.6715-6720.1999 · Cited by 369
Self-citationControl of HIV despite the Discontinuation of Antiretroviral Therapy
Lisziewicz, J., Rosenberg, E. S., Lieberman, J., Jessen, H. K., Lopalco, L., Siliciano, R. F., Walker, B. D., & Lori, F. (1999) · New England Journal of Medicine · doi:10.1056/nejm199905273402114 · Cited by 324
Self-citationFaure, S., Meyer, L., Costagliola, D., Vaneensberghe, C., Genin, E., Autran, B., ALT, F., Groups, I. S., Delfraissy, J.-F., Group, S. S., et al. (2000) · Science · doi:10.1126/science.287.5461.2274 · Cited by 323
Harrer, T., Harrer, E., Kalams, S. A., Barbosa, P., Trocha, A., Johnson, R. P., Elbeik, T., Feinberg, M. B., Buchbinder, S. P., & Walker, B. D. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.7.2616 · Cited by 319
Self-citationMolecular cloning of NKB1. A natural killer cell receptor for HLA-B allotypes
D'Andrea, A., Chang, C., Franz-Bacon, K., McClanahan, T., Phillips, J. H., & Lanier, L. L. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.5.2306 · Cited by 310
New Class I and II HLA Alleles Strongly Associated with Opposite Patterns of Progression to AIDS
Hendel, H., Caillat-Zucman, S., Lebuanec, H., Carrington, M., O’Brien, S., Andrieu, J.-M., Schächter, F., Zagury, D., Rappaport, J., Winkler, C., et al. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.11.6942 · Cited by 296
Natural Killer Cells: From No Receptors to Too Many
Lanier, L. L. (1997) · Immunity · doi:10.1016/s1074-7613(00)80280-0 · Cited by 222
Tomiyama, H., Miwa, K., Shiga, H., et al. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.10.5026 · Cited by 81
Shankar, P., Xu, Z., & Lieberman, J. (1999) · Blood · doi:10.1182/blood.v94.9.3084 · Cited by 75
Brettle, R. P., McNeil, A. J., Burns, S. M., Gore, S. M., Bird, A. G., YAP, P. L., MacCallum, L., Leen, C. L. S., & Richardson, A. M. (1996) · AIDS · doi:10.1097/00002030-199604000-00011 · Cited by 56
Natural Killer Cell–mediated Lysis of Autologous Cells Modified by Gene Therapy
Liberatore, C., Capanni, M., Albi, N., Volpi, I., Urbani, E., Ruggeri, L., Mencarelli, A., Grignani, F., & Velardi, A. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.12.1855 · Cited by 33
Koblin, B. A., BENTHEM, B. H. B. V., Buchbinder, S., et al. (1999) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009926 · Cited by 30
Self-citation
Cited by
Lanier, L. L. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115526 · Cited by 2,769
Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS
Martin, M. P., Gao, X., Lee, J.-H., Nelson, G. W., Detels, R., Goedert, J. J., Buchbinder, S., Hoots, K., Vlahov, D., Trowsdale, J., et al. (2002) · Nature Genetics · doi:10.1038/ng934 · Cited by 1,189
Self-citationThe Major Genetic Determinants of HIV-1 Control Affect HLA Class I Peptide Presentation
Study, T. I. H. C. (2010) · Science · doi:10.1126/science.1195271 · Cited by 1,171
Migueles, S. A., Laborico, A. C., Shupert, W. L., Sabbaghian, M. S., Rabin, R., Hallahan, C. W., Baarle, D. V., Kostense, S., Miedema, F., McLaughlin, M., et al. (2002) · Nature Immunology · doi:10.1038/ni845 · Cited by 1,005
KIR: Diverse, Rapidly Evolving Receptors of Innate and Adaptive Immunity
Vilches, C., & Parham, P. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.092501.134942 · Cited by 986
Metadata
- Authors
- Flores-Villanueva, P. O., Yunis, E. J., Delgado, J. C., Vittinghoff, E., Buchbinder, S., Leung, J. Y., Uglialoro, A. M., Clavijo, O. P., Rosenberg, E. S., Kalams, S. A., Braun, J. D., Boswell, S. L., Walker, B. D., & Goldfeld, A. E.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2001-04-17
- Volume
- 98
- Issue
- 9
- Pages
- 5140-5145
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2157824753
- Cited by
- 263
- References
- 31
- FWCI
- 5.14
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.